MSF calls for new price of anti-TB drug delamanid to be lowered and offered outside of South Africa
Geneva – Doctors Without Borders/Médecins Sans Frontières (MSF) acknowledges the lower price offered to the government of South Africa for newer anti-tuberculosis (TB) drug, delamanid, but calls for it to be significantly lower and expanded